A Phase Ⅱ Clinical Study of 9MW1411 Injection in Acute Bacterial Skin and Skin Structure Infections
Condition: Skin Infection Interventions: Combination Product: 9MW1411 injection 1 combined with Linezolid; Combination Product: 9MW1411 injection 2 combined with Linezolid; Combination Product: 9MW1411 injection placebo combined with Linezolid Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 21, 2022 Category: Research Source Type: clinical trials
A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China
Condition: Tuberculosis, Multidrug-Resistant Interventions: Drug: Bedaquiline; Drug: Levofloxacin; Drug: Linezolid; Drug: Cycloserine; Drug: Clofazimine; Drug: Pyrazinamide; Drug: Protionamide Sponsor: Beijing Chest Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2022 Category: Research Source Type: clinical trials
